Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against bioxcel therapeutics, inc. (btai)

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”) reminds investors of the upcoming september 5, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired bioxcel therapeutics, inc. (“bioxcel” or the “company”) (nasdaq: btai) securities between december 15, 2021 and june 28, 2023, inclusive (the “class period”). if you suffered a loss on your bioxcel investments or would like to inquire about potentiall.
BTAI Ratings Summary
BTAI Quant Ranking